#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myasthenia gravis Cutaneous T-cell lymphoma stage I Chronic lymphocytic leukaemia refractory Retinal artery occlusion Peripheral T-cell lymphoma unspecified Chronic myeloid leukaemia (in remission) Small intestine neuroendocrine tumour Liposarcoma recurrent Laryngeal squamous cell carcinoma Cystic fibrosis gastrointestinal disease Fibrous dysplasia of bone Non-small cell lung cancer Spinal cord injury Oropharyngeal cancer recurrent Small intestine adenocarcinoma More trials…

    Learn about Rare Diseases

    Paroxysmal nocturnal haemoglobinuria – Treatment Kearns-Sayre syndrome – Trials in Disease Mantle cell lymphoma – Trials in Disease Nephroblastoma Cystic fibrosis – Diagnostics Nephroblastoma – Trials in Disease Chordoma – Basic Information Malignant fibrous histiocytoma – Life with Disease Leiomyosarcoma recurrent – Diagnostics Progressive supranuclear palsy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Alanyl Glutamine Adrenaline Tartrate Ph. Eur. Taurine Ep262 Protein S Cx-037231 Nefopam L-Histidine Csm-Gw Fluvastatin Sodium HYALURONIDASE Keto-Leucine Calcium Estradiol SOFTISAN 378 [18F] CANAGLIFLOZIN Lt3001 Dog Epithelium Extract Amoxicillin Chlorpromazine Hydrochloride Desoximetasone More therapies…

    Learn about Your Condition

    Thromboembolectomy Prostate cancer metastatic Oesophagogastroscopy Peyronie's disease Naevoid melanoma Pneumothorax Labour induction Dystonia Glioblastoma multiforme Proteus syndrome Kidney transplant rejection Kaposi's sarcoma Pouchitis Acquired ATTR amyloidosis Haemorrhage More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Heart Amyloidosis Using Sodium Fluoride (18F) and Iodine (123I) Iobenguane for Patients with Transthyretin Amyloid Cardiomyopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Iodine (123I) Iobenguane
    • Sodium Fluoride (18F)
    The Netherlands

  • Study on Antibiotic Combination of Ceftriaxone, Clarithromycin, and Metronidazole for Pregnant Women with Threatened Miscarriage and Intact Membranes

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Ceftriaxone Sodium
    • Clarithromycin
    • Metronidazole
    France

  • Study on Quality of Life and Brain Function in Patients with Diffuse Low-Grade Gliomas Treated with Temozolomide

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Temozolomide
    France

  • Comparison of Surgical Treatment versus Cabergoline in Patients with Newly Diagnosed Microprolactinomas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Prolactin-producing pituitary tumour
    Investigated Drugs:
    • Cabergoline
    Italy

  • Study on the Safety and Tumor-Fighting Effects of OMO-103 for Patients with Advanced Osteosarcoma

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Osteosarcoma metastatic
    Investigated Drugs:
    • Omo-103
    Spain

  • Detecting Heart Inflammation in Cardiac Sarcoidosis Patients Using 68Ga-NOTA-Anti-MMR-VHH2 PET-CT Imaging

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac sarcoidosis
    Investigated Drugs:
    • Nanobody Against Macrophage Mannose Receptor, Conjugated With 1,4,7-Triazacyclononane-N,N’,N”-Triacetic Acid, Labelled With Gallium Ga-68
    Belgium
Previous Page
1 … 840 841 842 843 844 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!